scholarly journals Behavioral activation therapy for depression and anxiety in cancer patients: a case series study

2019 ◽  
Vol 13 (1) ◽  
Author(s):  
Takatoshi Hirayama ◽  
Yuko Ogawa ◽  
Yuko Yanai ◽  
Shin-ichi Suzuki ◽  
Ken Shimizu
2009 ◽  
Vol 40 (4) ◽  
pp. 346-356 ◽  
Author(s):  
Derek R. Hopko ◽  
Sarah M.C. Robertson ◽  
John P. Carvalho

2018 ◽  
Vol 12 (2) ◽  
pp. 46-57 ◽  
Author(s):  
Valery Krupnik

A novel evolutionary-based therapy, treating depression downhill (TDD), was designed as a specific therapy for depression as a syndrome (Krupnik, 2014) and later integrated with eye movement desensitization and reprocessing (EMDR) therapy into a combined TDD-EMDR treatment. The combined therapy integrates modified EMDR procedures into the theoretical context of TDD. These procedures are applied during the second (acceptance) stage of TDD-EMDR’s three-stage proltocol with the focus on acceptance of defeat/failure/loss rather than on distressing memories. Here, we report a case series of 21 military personnel diagnosed with depressive disorders, who received a course of TDD-EMDR. Eighty percent of completers (n = 15) did not meet the criteria of depressive disorder by the treatment’s end. After 12 sessions, they showed a significant reduction on the Beck’s Depression Inventory-II (BDI-II) with a large effect size (d = 2.8) and an increase in accepting disposition (d = 1.8) on the Acceptance and Action Questionnaire. Noncompleters showed similar to completers decrease of BDI-II scores at mid-treatment. We observed no statistically significant decrease of the anxiety symptoms on the Beck’s Anxiety Inventory. These results suggest that TDD-EMDR may be an effective treatment for depressive disorders. They also indicate that it may preferentially target depressive over anxiety symptoms, as was previously observed for TDD. Suggestions are made for future research.


2013 ◽  
Vol 22 (3) ◽  
pp. 795-801 ◽  
Author(s):  
Angela Maria Sousa ◽  
José de Santana Neto ◽  
Gabriel M. N. Guimaraes ◽  
Giovana M. Cascudo ◽  
José Osvaldo B. Neto ◽  
...  

Medicina ◽  
2021 ◽  
Vol 57 (9) ◽  
pp. 907
Author(s):  
Francois H. Cornelis ◽  
Leo Razakamanantsoa ◽  
Mohamed Ben Ammar ◽  
Milan Najdawi ◽  
Francois Gardavaud ◽  
...  

Background and objectives: Cancer-related vertebral compression fractures (VCF) may cause debilitating back pain and instability, affecting the quality of life of cancer patients. To further drive cement deposition during vertebroplasty, the aims of this restrospective case series study were to report the feasibility, safety and short term efficacy (≤6 months) of percutaneous vertebral fixation in cancer-related vertebral compression fractures using various intravertebral implants. Methods: All consecutive cancer patients treated with percutaneous vertebral fixation for VCF were retrospectively included. Various devices were inserted percutaneously under image guidance and filled by cement. Descriptive statistics were used and a matched paired analysis of pain scores was performed to assess for changes following interventions. Results: A total of 18 consecutive patients (12 women (66.6%) and 6 men (33.3%); mean age 59.7 ± 15.5 years) were included. A total of 42 devices were inserted in 8 thoracic and 16 lumbar vertebrae. Visual analogue scale measurement significantly improved from 5.6 ± 1.8 preoperatively to 1.5 ± 1.7 at 1 week (p < 0.01) and to 1.5 ± 1.3 at 6 months (p < 0.01). No severe adverse events were observed, but three adjacent fractures occurred between 1 week and 5 months after implantation. Conclusions: Percutaneous vertebral fixation of cancer-related VCF is feasible and safe and allows pain relief.


Sign in / Sign up

Export Citation Format

Share Document